FrancophonIA/ELRC3.0 huggingface dataset:
English: Prepare the syringes for injection by drawing 0.8 mL of the diluted solution into each sterile 1 mL syringe.
Croatian: Pripremite štrcaljke za injekciju tako što ćete izvući 0,8 ml razrijeđene otopine u svaku sterilnu štrcaljku od 1 ml.
English: The diluted solution should be clear to slightly opalescent.
Croatian: Razrijeđena otopina mora biti bistra do blago opalescentna.
English: Subretinal use
Croatian: Subretinalna primjena
English: Luxturna is indicated for the treatment of adult and paediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells.
Croatian: Luxturna je indicirana za liječenje odraslih i pedijatrijskih bolesnika s gubitkom vida zbog naslijeđene distrofije mrežnice uzrokovane potvrđenim bialelnim RPE65 mutacijama, koji imaju dovoljno vijabilnih stanica mrežnice.
English: • You should avoid swimming because of an increased risk of infection in the eye.
Croatian: • Izbjegavajte plivanje zbog povećanog rizika od infekcije oka.
English: • Under direct visualisation, the tip of the subretinal injection cannula is placed in contact with the retinal surface.
Croatian: • Uz izravnu vizualizaciju, vrh kanile za subretinalnu injekciju postavlja se u dodir s površinom mrežnice.
English: • Eye inflammation (including endophthalmitis), retinal tear and retinal detachment.
Croatian: • Upala oka (uključujući endoftalmitis), ruptura mrežnice i ablacija mrežnice.
English: The product is slowly injected through the extension tube and subretinal injection cannula to eliminate any air bubbles.
Croatian: Lijek se polako injicira kroz produžnu cjevčicu i kanilu za subretinalnu injekciju kako bi se uklonili mogući mjehurići zraka.
English: Accidental exposure
Croatian: Slučajno izlaganje
English: • Supine head positioning is initiated immediately in the post-operative period and upon discharge should be maintained by the patient for 24 hours.
Croatian: • Glava se odmah postavlja vodoravno okrenuta prema gore u postoperativnom razdoblju, a nakon otpusta bolesnik je treba tako držati 24 sata.
English: Intraocular pressure should be monitored prior to and following administration of the medicinal product and managed appropriately.
Croatian: Potrebno je pratiti intraokularni tlak prije i nakon primjene lijeka te ga na odgovarajući način kontrolirati.
English: • Accidental exposure to voretigene neparvovec, including contact with skin, eyes and mucous membranes, is to be avoided.
Croatian: • Treba izbjegavati slučajno izlaganje voretigen neparvoveku, uključujući kontakt s kožom, očima i sluznicama.
English: Luxturna is used for the treatment of adults and children with vision loss due to inherited retinal dystrophy caused by mutations in the RPE65 gene.
Croatian: Luxturna se koristi za liječenje odraslih i djece s gubitkom vida uzrokovanim nasljednom distrofijom mrežnice koju uzrokuju mutacije u RPE65 genu.
English: Luxturna is a concentrate for solution for subretinal injection that requires thawing and dilution prior to administration.
Croatian: Luxturna je koncentrat za otopinu za subretinalnu injekciju koji se mora odmrznuti i razrijediti prije primjene.
English: Luxturna has not been studied in breast-feeding women.
Croatian: Luxturna nije bila ispitivana u dojilja.
English: Prepare the syringes for injection by drawing 0.8 mL of the diluted solution into a sterile 1 mL syringe.
Croatian: Pripremite štrcaljke za injekciju tako što ćete izvući 0,8 ml razrijeđene otopine u sterilnu štrcaljku od 1 ml.
English: 0.5 mL extractable volume of concentrate in 2 mL cyclic olefin polymer vial with a chlorobutyl rubber stopper sealed in place with an aluminium flip-off seal.
Croatian: 0,5 ml raspoloživog volumena koncentrata u bočici od 2 ml od cikličkog olefinskog polimera s čepom od klorobutilne gume koji je zapečaćen zaštitnim aluminijskim prstenom s flip-off kapicom.
English: Prednisone (or equivalent) 0.5 mg/kg/day (maximum of 20 mg/day)
Croatian: Prednizon (ili ekvivalent) 0,5 mg/kg/dan (najviše 20 mg/dan)
English: It is unknown whether voretigene neparvovec is excreted in human milk.
Croatian: Nije poznato izlučuje li se voretigen neparvovek u majčino mlijeko.
English: Refer to local biosafety guidelines applicable for disposal of the product.
Croatian: Proučite lokalne smjernice za biosigurnost koje se odnose na zbrinjavanje lijeka.
English: Store and transport frozen at ≤-65 ºC.
Croatian: Čuvati i prevoziti zamrznuto na ≤ -65 ºC.
English: Electrocardiogram T wave inversion Injury, poisoning and procedural complications Common
Croatian: Često inverzija T vala na elektrokardiogramu Ozljede, trovanja i proceduralne komplikacije Često komplikacije s endotrahealnom intubacijom, dehiscencija rane
English: Gently invert the vials five times to mix the contents.
Croatian: Lagano preokrenite bočice pet puta da se pomiješa sadržaj.
English: • Cataract (clouding of the lens)
Croatian: • Mrena (zamućenje leće)
English: Each carton containing 1 vial of concentrate and 2 vials of solvent is for single use only.
Croatian: Jedna kutija koja sadrži 1 bočicu koncentrata i 2 bočice otapala namijenjena je samo za jednokratnu uporabu.
English: Administration Follow the steps below to administer voretigene neparvovec to patients:
Croatian: Primjena Slijedite korake u nastavku za primjenu voretigen neparvoveka bolesnicima:
English: Personal protective equipment (to include laboratory coat, safety glasses and gloves) should be worn while preparing or administering voretigene neparvovec (see section 6.6).
Croatian: Potrebno je nositi opremu za osobnu zaštitu (koja uključuje laboratorijsku kutu, zaštitne naočale i rukavice) za vrijeme pripreme ili primjene voretigen neparvoveka (vidjeti dio 6.6).
English: Figure 1 Tip of the subretinal injection cannula placed within recommended injection site (surgeon's view)
Croatian: Slika 1 Vršak kanile za subretinalnu injekciju postavljen unutar preporučenog mjesta za primjenu injekcije (iz perspektive kirurga)
English: The product filled syringes should then be transferred in a designated transport container to the surgical suite.
Croatian: Štrcaljke napunjene lijekom zatim treba prenijeti u za to određenom spremniku za transport do operacijske sale.
English: Transfer 2.7 mL of solvent taken from the two thawed vials and dispense into a sterile 10 mL empty glass vial using a 3 mL syringe.
Croatian: Prenesite 2,7 ml otapala iz dvije odmrznute bočice i stavite u sterilnu praznu staklenu bočicu od 10 ml pomoću štrcaljke od 3 ml.
English: How Luxturna is given to you
Croatian: Kako se Luxturna primjenjuje
English: The nine subjects who were randomised to the control group were crossed over to receive subretinal injection of voretigene neparvovec after one year of observation.
Croatian: Devet ispitanika koji su bili randomizirani u kontrolnu skupinu prebačeni su nakon godine dana promatranja u drugu skupinu kako bi primili subretinalnu injekciju voretigen neparvoveka.
English: 1.7 mL extractable volume of solvent in a 2 mL cyclic olefin polymer vial with a chlorobutyl rubber stopper sealed in place with an aluminium flip-off seal.
Croatian: 1,7 ml raspoloživog volumena otapala u bočici od 2 ml od cikličkog olefinskog polimera s čepom od klorobutilne gume koji je zapečaćen zaštitnim aluminijskim prstenom s flip-off kapicom.
English: Figure 1B Tip of the subretinal injection cannula placed within the recommended site of injection (surgeon's view)
Croatian: Slika 1B Vršak kanile za subretinalnu injekciju postavljen unutar preporučenog mjesta za primjenu injekcije (iz perspektive kirurga)
English: Retinal tear, dellen, macular hole, eye inflammation, eye irritation, eye pain, maculopathy, choroidal haemorrhage, conjunctival cyst, eye disorder, eye swelling, foreign body sensation in eyes, macular degeneration, endophthalmitis, retinal detachment, retinal disorder, retinal haemorrhage
Croatian: Često ruptura mrežnice, ulegnuća na rubu rožnice, rupa u makuli, upala oka, nadražaj oka, bol u oku, makulopatija, krvarenje u žilnici, cista konjunktive, poremećaj oka, oticanje oka, osjećaj stranog tijela u očima, makularna degeneracija, endoftalmitis, ablacija mrežnice, poremećaj mrežnice, krvarenje u mrežnici
English: Transient and low-level vector shedding may occur in patient tears (see section 5.2).
Croatian: U bolesnikovim suzama može doći do izlučivanja vektora koje je prolazno i niske razine (vidjeti dio 5.2).
English: - Treat all Luxturna spills with a virucidal agent such as 1% sodium hypochlorite and blot using absorbent materials.
Croatian: • Prolivena Luxturna mora se tretirati virucidnim sredstvom kao što je 1%-tni natrijev hipoklorit i upiti upijajućim materijalom.
English: • Connect the syringe containing the diluted product to the extension tube and subretinal injection cannula.
Croatian: • Spojite štrcaljku koja sadrži razrijeđeni lijek na produžnu cjevčicu i kanilu za subretinalnu injekciju.
English: XY1
Croatian: XG1
English: • Deposits under the retina
Croatian: • Nakupine ispod mrežnice
English: Precaution to be taken before manipulating or administering the product Personal protective equipment (to include laboratory coat, safety glasses and gloves) should be worn while preparing or administering voretigene neparvovec.
Croatian: Mjere opreza koje je potrebno poduzeti prije rukovanja ili primjene lijeka Potrebno je nositi opremu za osobnu zaštitu (koja uključuje laboratorijsku kutu, zaštitne naočale i rukavice) za vrijeme pripreme ili primjene voretigen neparvoveka.
English: vector genomes of voretigene neparvovec in a deliverable volume of 0.3 mL.
Croatian: vektorskih genoma voretigen neparvoveka u isporučivom volumenu od 0,3 ml.
English: Subretinal use.
Croatian: Način primjene Subretinalno.
English: Following the administration, patients should be instructed to report any symptoms suggestive of retinal detachment or endophthalmitis without delay and should be managed appropriately.
Croatian: Nakon primjene bolesnike treba uputiti da odmah prijave sve simptome koji bi mogli ukazivati na odignuće mrežnice ili endoftalmitis te ih zbrinuti na odgovarajući način.
English: For dilution, draw 0.3 mL of thawed concentrate into a 1 mL syringe and add it to the 10 mL sterile vial containing the solvent.
Croatian: Za razrjeđivanje izvucite 0,3 ml odmrznutog koncentrata u štrcaljku od 1 ml i dodajte ga u sterilnu bočicu od 10 ml koja sadrži otapalo.
English: If particulates, cloudiness, or discoloration are visible, the medicinal product must not be used.
Croatian: Ako su vidljive čestice, zamućenost ili promjena boje, lijek se ne smije koristiti.
English: Patients should be instructed to avoid air travel or other travel to high elevations until the air bubble formed as a result of administration of Luxturna has completely dissipated from the eye. A time period of up to one week or more following injection may be required before dissipation of the air bubble; this should be verified on ophthalmic examination.
Croatian: Bolesnike je potrebno uputiti da izbjegavaju putovanje avionom ili drugim prijevoznim sredstvima na velikim nadmorskim visinama dok mjehurić zraka koji nastane uslijed primjene Luxturne potpuno ne nestane iz oka.
English: Concentrate and solvent for solution for injection
Croatian: Koncentrat i otapalo za otopinu za injekciju
English: Concentrate and solvent for solution for injection.
Croatian: Koncentrat i otapalo za otopinu za injekciju.
English: Pre-operative
Croatian: Prije operacije
English: What Luxturna looks like and contents of the pack Luxturna is a clear, colourless concentrate for solution for subretinal injection, supplied in a clear plastic vial.
Croatian: Luxturna je bistar, bezbojan koncentrat za otopinu za subretinalnu injekciju, koji se isporučuje u prozirnoj plastičnoj bočici.
English: Y3
Croatian: G3
English: Unopened frozen vials
Croatian: Neotvorene zamrznute bočice 2 godine
English: • Nausea (feeling sick), vomiting, abdominal (belly) pain, lip pain
Croatian: • Mučnina, povraćanje, bol u gornjem dijelu trbuha, bol u usnicama
English: • Redness of the eye
Croatian: • Oticanje u oku
English: Patients should be instructed to report any symptoms suggestive of endophthalmitis or retinal detachment without delay and should be managed appropriately.
Croatian: Bolesnike je potrebno uputiti da odmah bez odgađanja prijave sve simptome koji ukazuju na endoftalmitis ili ablaciju mrežnice te ih je potrebno primjereno zbrinuti.
English: Excipients: sodium chloride, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate dihydrate, poloxamer 188, water for injections.
Croatian: Pomoćne tvari: natrijev klorid, natrijev dihidrogenfosfat hidrat, natrijev hidrogenfosfat dihidrat, poloksamer 188, voda za injekcije.
English: Nausea, vomiting, abdominal pain upper, lip pain Skin and subcutaneous disorders Common
Croatian: Često mučnina, povraćanje, bol u gornjem dijelu abdomena, bol u usnicama Poremećaji kože i potkožnog tkiva Često osip, oticanje lica
English: Each dose of diluted solution contains 1.5 x 10
Croatian: Jedna doza razrijeđene otopine sadrži 1,5 x 10
English: Eye disorders Very common
Croatian: Poremećaji oka Često retinalni depoziti
English: vg voretigene neparvovec in each eye. Each dose will be delivered into the subretinal space in a total volume of 0.3 mL.
Croatian: Svaka će doza biti primijenjena u subretinalni prostor u ukupnom volumenu od 0,3 ml.
English: The following side effects may happen with Luxturna:
Croatian: Uz Luxturnu može doći do sljedećih nuspojava:
English: BL: baseline;
Croatian: BL (Baseline) = Početak praćenja
English: vector genomes of voretigene neparvovec.
Croatian: vektorskih genoma voretigen neparvoveka.
English: Inspect for any visual particulates.
Croatian: Pregledajte ima li kakvih vidljivih čestica.
English: If particulates, cloudiness, or discoloration are visible, the single-dose vial must not be used.
Croatian: Ako su vidljive čestice, zamućenost ili promjena boje, jednodozna bočica se ne smije upotrijebiti.
English: Local biosafety guidelines for preparation, administration and handling of voretigene neparvovec should be followed.
Croatian: Potrebno je slijediti lokalne smjernice za biološki opasne materijale kod pripreme, primjene i rukovanja voretigen neparvovekom.
English: vector genomes/mL concentrate for solution for injection voretigene neparvovec
Croatian: vektorskih genoma/ml koncentrat za otopinu za injekciju voretigen neparvovek
English: • Personal protective equipment (to include laboratory coat, safety glasses and gloves) should be worn while preparing or administering voretigene neparvovec.
Croatian: • Potrebno je nositi osobnu zaštitnu opremu (što uključuje laboratorijsku kutu, zaštitne naočale i rukavice) tijekom pripreme ili primjene voretigen neparvoveka.
English: Gently invert the thawed solvent vials five times to mix the contents.
Croatian: Lagano preokrenite odmrznute bočice otapala pet puta da se pomiješa sadržaj.
English: Year 1
Croatian: Početak ispitivanja 1. godina
English: • Break in the retina
Croatian: • Pukotina u mrežnici
English: Gently invert the vial at least five times for proper mixing.
Croatian: Lagano preokrenite bočicu najmanje pet puta da bi se sadržaj dobro promiješao.
English: 31 December
Croatian: 31. prosinac 2031.
English: The other ingredients of the concentrate are sodium chloride (see end of section 2), sodium dihydrogen phosphate monohydrate (for pH adjustment), disodium hydrogen phosphate dihydrate (for pH adjustment), poloxamer 188 and water for injections.
Croatian: Ostali sastojci koncentrata su natrijev klorid (vidjeti kraj dijela 2), natrijev dihidrogenfosfat hidrat (za prilagodbu pH), natrijev hidrogenfosfat dihidrat (za prilagodbu pH), poloksamer 188 i voda za injekcije.
English: Nervous system disorders Common
Croatian: Poremećaji probavnog sustava
English: Discard unused product.
Croatian: Odbaciti neiskorišteni lijek.
English: Y1
Croatian: G1
English: vector genomes/mL concentrate and solvent for solution for injection voretigene neparvovec
Croatian: vektorskih genoma/ml koncentrat i otapalo za otopinu za injekciju voretigen neparvovek
English: vector genomes/mL concentrate and solvent for solution for injection
Croatian: vektorskih genoma/ml koncentrat i otapalo za otopinu za injekciju
English: Full-field light sensitivity testing - Second assigned eye (ITT) Intervention, N = 21
Croatian: - Drugo oko (ITT) Intervencijska skupina, N = 21
English: Full-field light sensitivity testing - First assigned eye (ITT) Intervention, N = 21
Croatian: - Prvo oko (ITT) Intervencijska skupina, N = 21
English: Y2
Croatian: G2
English: The solvent contains sodium chloride (see end of section 2), sodium dihydrogen phosphate monohydrate (for pH adjustment), disodium hydrogen phosphate dihydrate (for pH adjustment), poloxamer 188 and water for injections.
Croatian: Otapalo sadrži natrijev klorid (vidjeti kraj dijela 2), natrijev dihidrogenfosfat hidrat (za prilagodbu pH), natrijev hidrogenfosfat dihidrat (za prilagodbu pH), poloksamer 188 i vodu za injekcije.
English: Presence of a specialist ophthalmologist with expertise in care and treatment of patients with inherited retinal dystrophy (IRD);
Croatian: Kriteriji za ispitivačke centre/centre za liječenje trebaju uključivati: Prisutnost specijalista oftalmologa s ekspertizom u njezi i liječenju bolesnika s nasljednom retinalnom distrofijom;
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE NALJEPNICA BOČICE (KONCENTRAT)
English: Rash, swelling face
Croatian: • Osip, oticanje lica
English: Breast-feeding
Croatian: SPKRPE-EUPASS:
English: Sodium dihydrogen phosphate monohydrate (for pH adjustment) Disodium hydrogen phosphate dihydrate (for pH adjustment) Poloxamer 188
Croatian: Koncentrat natrijev klorid natrijev dihidrogenfosfat hidrat (za prilagodbu pH) natrijev hidrogenfosfat dihidrat (za prilagodbu pH) poloksamer 188 voda za injekcije
English: Intraocular pressure increased
Croatian: Pretrage Vrlo često povišeni intraokularni tlak
English: • Eye swelling
Croatian: • Crvenilo oka
English: • Eye pain
Croatian: • Bol u oku
English: Psychiatric disorders Common
Croatian: Psihijatrijski poremećaji Često anksioznost
English: Conjunctival hyperaemia, cataract
Croatian: Poremećaji oka Vrlo često hiperemija konjunktive, katarakta
English: Anxiety
Croatian: Izlučivanje
English: Retinal deposits
Croatian: Prijavljivanje nuspojava
English: Water for injections
Croatian: Preporučeno mjesto primjene injekcije
English: PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MEĐUPAKIRANJE KUTIJA
English: Date of first authorisation: 26 February 2015
Croatian: Datum prvog odobrenja: 26. veljače 2015.
English: Changing treatment:
Croatian: Promjena liječenja:
English: This effect is observed after 2 weeks is maintained with long-term treatment.
Croatian: Ovaj se učinak se primjećuje nakon 2 tjedna i održava se dugotrajnim liječenjem.
English: This was not confirmed in a dog study or in clinical trials.
Croatian: To nije potvrđeno u ispitivanju na psima niti u kliničkim ispitivanjima.
English: Currently, no formal carcinogenicity data are available.
Croatian: Trenutno nema dostupnih službenih podataka o karcinogenosti.
English: Long term chronic treatment
Croatian: Dugotrajno kronično liječenje
English: The amount of phosphate then rises (your doctor will call this hyperphosphataemia).
Croatian: Količina fosfata tada raste (Vaš liječnik će to nazvati hiperfosfatemija).
English: ATC code: V03AE02.
Croatian: ATK oznaka: V03AE02.
English: The safety and efficacy in children (below the age of 18 years) have not been studied.
Croatian: Sigurnost primjene i djelotvornost u djece (mlađe od 18 godina) nisu ispitivane.
English: The recommended starting dose of Tasermity for adults and the elderly (> 65 years) is one or two tablets with each meal 3 times a day.
Croatian: Preporučena početna doza lijeka Tasermity za odrasle i starije osobe (>65 godina) je jedna do dvije tablete uz svaki obrok 3 puta na dan.
English: • develop a low or high level of calcium in your blood.
Croatian: • razviti nisku ili visoku razinu kalcija u krvi.
English: • have a low amount of vitamin D in your blood.
Croatian: • imati niske razine vitamina D u krvi.
English: • if you are not on dialysis
Croatian: • ako niste na dijalizi
English: • if you have low levels of phosphate in your blood (your doctor will check this for you).
Croatian: • ako imate niske razine fosfata u krvi (vaš liječnik će obaviti provjeru)
English: 1 tablet, 3 times per day 2 tablets, 3 times per day
Croatian: 1 tableta, 3 puta na dan
English: What you need to know before you take Tasermity 3.
Croatian: Što morate znati prije nego što počnete uzimati Tasermity 3.
English: • if you are allergic to sevelamer or to any of the other ingredients of this medicine (listed in section 6).
Croatian: • ako ste alergični na sevelamer ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
English: 1411 DD Naarden The Netherlands
Croatian: 1411 DD Naarden Nizozemska
English: Therefore Tasermity is not recommended for use in this population.
Croatian: Stoga se ne preporučuje primjena lijeka Tasermity u toj populaciji.
English: Triglycerides, HDL cholesterol and albumin did not change.
Croatian: Vrijednosti triglicerida, HDL-kolesterola i albumina nisu se promijenile.
English: Other medicines and Tasermity
Croatian: Drugi lijekovi i Tasermity
English: In clinical trials mean total and LDL cholesterol declined by 15-31%.
Croatian: U kliničkim je ispitivanjima srednja vrijednost ukupnog i LDL-kolesterola smanjena za 15-31%.
English: If you take more Tasermity than you should
Croatian: Ako uzmete više lijeka Tasermity nego što ste trebali
English: Also the medicinal product is not absorbed in the gastrointestinal tract.
Croatian: Također, lijek se ne apsorbira u gastrointestinalnom traktu.
English: The marketing authorisation holder shall submit the first periodic safety update report for this product with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines webportal.
Croatian: Nositelj odobrenja će prvo periodičko izvješće o neškodljivosti za ovaj lijek podnijeti u skladu s referentnim popisom datuma EU (EURD popis) predviđenim člankom 107(c) stavkom 7 Direktive 2001/83/EZ i objavljenim na europskom internetskom portalu za lijekove.
English: Your doctor will check for interactions between Tasermity and other medicines on a regular basis.
Croatian: Liječnik će redovito provjeravati jesu li nastupile interakcije između lijeka Tasermity i drugih lijekova.
English: The dose range may vary between 1 and 5 tablets of 800 mg per meal.
Croatian: Raspon doze može varirati između 1 i 5 tableta od 800 mg po obroku.
English: There are no data from the effect of sevelamer on fertility in humans.
Croatian: Nema podataka o utjecaju sevelamera na plodnost u ljudi.
English: As data on the chronic use of sevelamer hydrochloride for over one year are not yet available, potential absorption and accumulation of sevelamer during long-term chronic treatment cannot be totally excluded (see section 5.2).
Croatian: Budući da još nisu dostupni podaci o kroničnoj primjeni sevelamerklorida dulje od jedne godine, ne može se potpuno isključiti mogućnost apsorpcije i akumulacije sevelamera tijekom dugotrajnog kroničnog liječenja (vidjeti dio 5.2).
English: What Tasermity is and what it is used for 2.
Croatian: Što je Tasermity i za što se koristi 2.
English: The effects on phosphate and calcium were proven to be maintained throughout a study with one year follow-up.
Croatian: Pokazalo se da su učinci na fosfat i kalcij održani tijekom cijelog ispitivanja uz jednogodišnje praćenje nakon ispitivanja.
English: Since Tasermity does not contain calcium your doctor might prescribe additional calcium tablets.
Croatian: Budući da Tasermity ne sadrži kalcij, liječnik Vam može propisati dodatno uzimanje tableta kalcija.